Tristel plc (LON:TSTL - Get Free Report) insider Paul Christopher Swinney sold 50,000 shares of the firm's stock in a transaction dated Tuesday, April 16th. The shares were sold at an average price of GBX 462 ($5.75), for a total transaction of £231,000 ($287,563.80).
Tristel Stock Performance
Shares of Tristel stock traded down GBX 5 ($0.06) during mid-day trading on Wednesday, hitting GBX 465 ($5.79). 54,378 shares of the stock were exchanged, compared to its average volume of 55,884. Tristel plc has a 12 month low of GBX 315 ($3.92) and a 12 month high of GBX 503.50 ($6.27). The company has a 50-day simple moving average of GBX 460.46 and a 200 day simple moving average of GBX 440.34. The company has a debt-to-equity ratio of 19.12, a quick ratio of 3.83 and a current ratio of 4.92. The company has a market capitalization of £220.83 million, a P/E ratio of 3,576.92 and a beta of 0.28.
Tristel Cuts Dividend
The company also recently announced a dividend, which was paid on Friday, April 12th. Shareholders of record on Thursday, March 21st were given a dividend of GBX 5.24 ($0.07) per share. The ex-dividend date was Thursday, March 21st. This represents a dividend yield of 1.16%. Tristel's dividend payout ratio is currently 10,000.00%.
About Tristel
(
Get Free Report)
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.
Further Reading
Before you consider Tristel, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tristel wasn't on the list.
While Tristel currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
